1. Botulinum toxin type A in simple motor tics: short-term and long-term treatment-effects
- Author
-
Agnes A.A.C.M. Wertenbroek, D.L.J. Tavy, Sebastiaan F T M de Bruijn, Judith J.G. Rath, and Theodoor C.A.M. van Woerkom
- Subjects
Adult ,Male ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Long term treatment ,Time Factors ,Tics ,Adolescent ,Motor tics ,Young Adult ,mental disorders ,medicine ,Reaction Time ,Effective treatment ,Humans ,Young adult ,Botulinum Toxins, Type A ,Duration of effect ,Aged ,Retrospective Studies ,Aged, 80 and over ,Middle Aged ,medicine.disease ,Botulinum toxin ,Surgery ,body regions ,Treatment Outcome ,Neurology ,Neuromuscular Agents ,Anesthesia ,Female ,Neurology (clinical) ,Geriatrics and Gerontology ,Psychology ,human activities ,medicine.drug ,Botulinum toxin type ,Follow-Up Studies - Abstract
To determine the short-term and long-term treatment-effects of botulinum toxin type A in simple motor tics, we analyzed 15 consecutive patients (18 tics) with simple motor tics that were treated every 3 months with injections of BTX-A. Efficacy (rated on a 4-level scale) and duration of effect of the first 2 and last 2 (if treated 5 times or more) treatments were recorded, as well as latency of response, changes of premonitory urges (PMUs) and possible side effects. Total number of treatments for each tic varied from 2 to 50 (mean 11, median 6). In 16 of 18 tics (89%) short-term efficacy was reported successful (good or moderate). Long-term efficacy was reported in 12 tics of which 11 showed similar or even increased beneficial effects. Premonitory urge (PMU) was reported in 8 patients (53%). PMU, if present, lessened or disappeared after treatment with BTX-A. A permanent remission of the treated tic was seen in 3 patients with a maximum follow-up of 10 years. BTX-A appears a safe and effective treatment for simple motor tics and retains its efficacy after long-term treatment. BTX may also induce permanent remission of the treated tics and effects of BTX are not restricted to merely motor behaviour.
- Published
- 2009